Talk:Panel-reactive antibody

Medicine Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.

Molecular Biology: MCB

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Mid-importance).

Human Genetic History (inactive)

This article is within the scope of WikiProject Human Genetic History, a project which is currently considered to be inactive.Human Genetic HistoryWikipedia:WikiProject Human Genetic HistoryTemplate:WikiProject Human Genetic HistoryHuman Genetic History articles

Untitled[edit]

This page should have a link from human leucocyte antigen, http://en.wikipedia.org/wiki/Human_leukocyte_antigen

Information on how the PRA test is conducted is at http://www.pancreas-kidney.com/hla.html

The PRA is a crude test. With low-cost antibody tests available today, it is now possible to specify which HLA antibodies the patient has. We also know the distribution of HLA allotypes in the general population, so a calculated PRA can be determined. Details at http://www.unos.org/resources/frm_CPRA_Calculator.asp?index=75 - Gtaniwaki 21:35 UTC, 24 March 2010‎